Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subjects With Impaired Renal Function and Healthy Subjects”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT06132204
What this trial is testing

Pharmacokinetic and Safety Studies of HRS-7535 in Subjects With Moderate Renal Insufficiency and Healthy Subjects

Who this might be right for
Type 2 Diabetes
Shandong Suncadia Medicine Co., Ltd. 16
Early research (Phase 1)Study completedNCT01934166
What this trial is testing

Pharmacokinetic Properties of Nalmefene in Subjects With Renal Impairment and in Healthy Subjects

Who this might be right for
Renal Impairment
H. Lundbeck A/S 32
Early research (Phase 1)Study completedNCT01846468
What this trial is testing

An Ascending Dose Study to Assess Safety, Tolerability, PK/PD of LHW090 in Healthy Volunteers and in Subjects With Renal Dysfunction

Who this might be right for
Chronic Renal Insufficiency
Novartis Pharmaceuticals 205
Early research (Phase 1)Study completedNCT05208814
What this trial is testing

Evaluate the Pharmacokinetics and Safety of TPN171H Tablets in Patients with Renal Insufficiency and Healthy Subjects

Who this might be right for
Pulmonary Arterial HypertensionErectile Dysfunction
Vigonvita Life Sciences 16
Early research (Phase 1)Study completedNCT03947970
What this trial is testing

Study to Evaluate the Pharmacokinetics and Metabolism of [14C] CR845 (Difelikefalin) in Patients With End Stage Renal Disease on Hemodialysis and in Healthy Subjects

Who this might be right for
HemodialysisHealthy
Cara Therapeutics, Inc. 12
Early research (Phase 1)Study completedNCT04024332
What this trial is testing

Study of the Way the Body Takes up, Distributes, and Gets Rid of ACT-541468 in Subjects With Abnormal Kidney Function Compared to Healthy Subjects

Who this might be right for
Renal InsufficiencyHealthy
Idorsia Pharmaceuticals Ltd. 16
Early research (Phase 1)Study completedNCT04154670
What this trial is testing

Study Assessing PK and Safety of MGTA-145 in Subjects With Normal Estimated GFR and Varying Degrees of Renal Impairment

Who this might be right for
HealthyRenal Insufficiency
Ensoma 23
Early research (Phase 1)Study completedNCT01730469
What this trial is testing

Safety and Pharmacokinetics of AT1001 (Migalastat HCl) in Healthy Subjects and Subjects With Impaired Renal Function

Who this might be right for
Fabry Disease
Amicus Therapeutics 32
Early research (Phase 1)Study completedNCT01318551
What this trial is testing

Single Dose Group Stratified Study in Renal Impaired and Healthy Aged and Gender Matched Subjects

Who this might be right for
Anemia
Bayer 56
Very early researchStudy completedNCT02998775
What this trial is testing

Phase 0 Study in Healthy, Hepatic and Renal Impaired Subjects to Obtain Plasma for Lenvatinib Protein Binding

Who this might be right for
Hepatic Impairment; Renal Impairment
Eisai Inc. 54
Early research (Phase 1)Study completedNCT01240967
What this trial is testing

To Compare the Pharmacokinetics of a Single Oral Dose of TC-5214 in Subjects With Renal Impairment and With Subjects With Normal Renal Function

Who this might be right for
Healthy VolunteersPatientsPharmacokinetics+1 more
AstraZeneca 40
Early research (Phase 1)Ended earlyNCT03241147
What this trial is testing

Pharmacokinetics of Lu AF35700 in Subjects With Renal Impairment

Who this might be right for
Renal Failure
H. Lundbeck A/S 23
Early research (Phase 1)Study completedNCT06698549
What this trial is testing

Evaluate the Pharmacokinetics, Safety and Tolerability of ALG-097558 in Subjects With Renal Impairment and in Healthy Subjects With Normal Renal Function

Who this might be right for
COVID 19
Aligos Therapeutics 12
Early research (Phase 1)Study completedNCT01613690
What this trial is testing

Comparing the Pharmacokinetics, Safety and Tolerability of NVA237 in Renal Impairment

Who this might be right for
Renal Impairment
Novartis Pharmaceuticals 48
Early research (Phase 1)Not Yet RecruitingNCT07797322
What this trial is testing

Investigate the Pharmacokinetics and Safety of PKN605 in Participants With Moderate and Severe Renal Impairment Compared to Matched Control Subjects With Normal Renal Function

Who this might be right for
Participants With Moderate and Severe Renal Impairment and Healthy Participants
Novartis Pharmaceuticals 40
Testing effectiveness (Phase 2)Study completedNCT01569828
What this trial is testing

Multiple Dose Pharmacokinetics of LCZ696 and Its Metabolites in Subjects With Severe Renal Impairment vs. Matched Healthy Subjects With Normal Renal Function

Who this might be right for
PharmacokineticsRenal ImpairedHealthy Volunteer
Novartis Pharmaceuticals 12
Early research (Phase 1)Study completedNCT02813798
What this trial is testing

Evaluate the Effect of IV Doses of Rivipansel on Subjects With Renal Impairment and in Healthy Subjects

Who this might be right for
Renal ImpairmentHealthy
GlycoMimetics Incorporated 28
Early research (Phase 1)Study completedNCT04532918
What this trial is testing

Pharmacokinetics of Verinurad and Allopurinol in Combination With Cyclosporine and Rifampicin in Healthy Volunteers

Who this might be right for
Chronic Kidney Disease
AstraZeneca 14
Not applicableStudy completedNCT03157960
What this trial is testing

Effect of Acute Fructose Load in Human

Who this might be right for
Chronic Kidney DiseasesDiabetes Mellitus, Type 2
Karolinska University Hospital 20
Early research (Phase 1)Study completedNCT01901133
What this trial is testing

Hepatic Impairment Study With MDV3100 in Subjects With Mild and Moderate Hepatic Impairment Compared to a Healthy Control Group

Who this might be right for
Pharmacokinetics of MDV3100Healthy SubjectsKidney Diseases
Astellas Pharma Europe B.V. 33
Next Page